Hives Clinical Research Studies
Hives, or urticaria are itchy red or skin-colored welts that can appear on the skin of people of all ages. These can be caused by numerous things such as an allergic reaction to a food or drug, however, experts are unsure of the exact cause of hives and urticaria. We are currently conducting a clinical research study investigating a new type of oral medication for the treatment of urticaria. Medication will be provided at no cost with no insurance needed for those who qualify, you will be reimbursed for your time and travel, and will receive care from physicians affiliated with the Clinical Research Center of Alabama.
Biologic Study-Ligelizumab versus Xolair
The purpose of the study is to evaluate the efficacy and safety of ligelizumab in treating adult and adolescent subjects with chronic spontaneous urticaria. Omalizumab (also called Xolair®) will be used as a comparator as this medication is the only drug in the same class as ligelizumab already approved to treat CSU patients when not adequately controlled with H1 antihistamines.
Investigational biologic infusion study
The main purpose of this study is to evaluate the effectiveness and safety profile of CDX-0159 in patients with chronic urticaria who remain symptomatic despite treatment with antihistamines.
Become a Participant in our Hives Studies
If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.